24 128
Kim, K., Doi, A., Wen, B., Ng, K., Zhao, R., Cahan, P., Kim, J., Aryee, M.J., Ji,
H., Ehrlich, L.I.R., et al. (2010). Epigenetic memory in induced pluripotent stem
cells. Nature
467
, 285–290.
Kleinstiver, B.P., Prew, M.S., Tsai, S.Q., Topkar, V.V., Nguyen, N.T., Zheng, Z.,
Gonzales, A.P., Li, Z., Peterson, R.T., Yeh, J.R., et al. (2015). Engineered
CRISPR-Cas9 nucleases with altered PAM specificities. Nature
523
, 481–485.
Kleinstiver, B.P., Prew, M.S., Tsai, S.Q., Nguyen, N.T., Topkar, V.V., Zheng, Z.,
and Joung, J.K. (2015a). Broadening the targeting range of Staphylococcus
aureus CRISPR-Cas9 by modifying PAM recognition. Nat. Biotechnol.
33
,
1293–1298.
Kleinstiver, B.P., Prew, M.S., Tsai, S.Q., Topkar, V.V., Nguyen, N.T., Zheng, Z.,
Gonzales, A.P., Li, Z., Peterson, R.T., Yeh, J.R., et al. (2015b). Engineered
CRISPR-Cas9 nucleases with altered PAM specificities. Nature
523
, 481–485.
Kleinstiver, B.P., Pattanayak, V., Prew, M.S., Tsai, S.Q., Nguyen, N.T., Zheng,
Z., and Joung, J.K. (2016). High-fidelity CRISPR-Cas9 nucleases with no
detectable genome-wide off-target effects. Nature
529
, 490–495.
Knight, S.C., Xie, L., Deng, W., Guglielmi, B., Witkowsky, L.B., Bosanac, L.,
Zhang, E.T., El Beheiry, M., Masson, J.B., Dahan, M., et al. (2015). Dynamics
of CRISPR-Cas9 genome interrogation in living cells. Science
350
, 823–826.
Konermann, S., Brigham, M.D., Trevino, A.E., Joung, J., Abudayyeh, O.O.,
Barcena, C., Hsu, P.D., Habib, N., Gootenberg, J.S., Nishimasu, H., et al.
(2015). Genome-scale transcriptional activation by an engineered CRISPR-
Cas9 complex. Nature
517
, 583–588.
Kotini, A.G., Chang, C.J., Boussaad, I., Delrow, J.J., Dolezal, E.K., Nagula-
pally, A.B., Perna, F., Fishbein, G.A., Klimek, V.M., Hawkins, R.D., et al.
(2015). Functional analysis of a chromosomal deletion associated with myelo-
dysplastic syndromes using isogenic human induced pluripotent stem cells.
Nat. Biotechnol.
33
, 646–655.
Kytta¨ la¨ , A., Moraghebi, R., Valensisi, C., Kettunen, J., Andrus, C., Pasumarthy,
K.K., Nakanishi, M., Nishimura, K., Ohtaka, M., Weltner, J., et al. (2016). Ge-
netic Variability Overrides the Impact of Parental Cell Type and Determines
iPSC Differentiation Potential. Stem Cell Reports
6
, 200–212.
Lancaster, M.A., and Knoblich, J.A. (2014). Organogenesis in a dish: modeling
development and disease using organoid technologies. Science
345
, 1247125.
Lancaster, M.A., Renner, M., Martin, C.A., Wenzel, D., Bicknell, L.S., Hurles,
M.E., Homfray, T., Penninger, J.M., Jackson, A.P., and Knoblich, J.A. (2013).
Cerebral organoids model human brain development and microcephaly. Na-
ture
501
, 373–379.
Li, Y., Wang, H., Muffat, J., Cheng, A.W., Orlando, D.A., Love´ n, J., Kwok, S.M.,
Feldman, D.A., Bateup, H.S., Gao, Q., et al. (2013). Global transcriptional and
translational repression in human-embryonic-stem-cell-derived Rett syn-
drome neurons. Cell Stem Cell
13
, 446–458.
Liang, P., Xu, Y., Zhang, X., Ding, C., Huang, R., Zhang, Z., Lv, J., Xie, X., Chen,
Y., Li, Y., et al. (2015). CRISPR/Cas9-mediated gene editing in human tripronu-
clear zygotes. Protein Cell
6
, 363–372.
Liao, J., and Karnik, R. (2015). Targeted disruption of DNMT1, DNMT3A and
DNMT3B in human embryonic stem cells. Nat. Genet.
47
, 469–478.
Lin, S., Staahl, B.T., Alla, R.K., and Doudna, J.A. (2014). Enhanced homology-
directed human genome engineering by controlled timing of CRISPR/Cas9
delivery. eLife
3
, e04766.
Lombardo, A., Genovese, P., Beausejour, C.M., Colleoni, S., Lee, Y.L., Kim,
K.A., Ando, D., Urnov, F.D., Galli, C., Gregory, P.D., et al. (2007). Gene editing
in human stem cells using zinc finger nucleases and integrase-defective lenti-
viral vector delivery. Nat. Biotechnol.
25
, 1298–1306.
Ma, N., Liao, B., Zhang, H., Wang, L., Shan, Y., Xue, Y., Huang, K., Chen, S.,
Zhou, X., Chen, Y., et al. (2013). Transcription activator-like effector nuclease
(TALEN)-mediated gene correction in integration-free
b
-thalassemia induced
pluripotent stem cells. J. Biol. Chem.
288
, 34671–34679.
Maeder, M.L., Angstman, J.F., Richardson, M.E., Linder, S.J., Cascio, V.M.,
Tsai, S.Q., Ho, Q.H., Sander, J.D., Reyon, D., Bernstein, B.E., et al. (2013). Tar-
geted DNA demethylation and activation of endogenous genes using pro-
grammable TALE-TET1 fusion proteins. Nat. Biotechnol.
31
, 1137–1142.
Maetzel, D., Sarkar, S., Wang, H., Abi-Mosleh, L., Xu, P., Cheng, A.W., Gao, Q.,
Mitalipova, M., and Jaenisch, R. (2014). Genetic and chemical correction of
cholesterol accumulation and impaired autophagy in hepatic and neural cells
derived from Niemann-Pick Type C patient-specific iPS cells. Stem Cell Re-
ports
2
, 866–880.
Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld,
M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007). Directly reprog-
rammed fibroblasts show global epigenetic remodeling and widespread tissue
contribution. Cell Stem Cell
1
, 55–70.
Mali, P., Yang, L., Esvelt, K.M., Aach, J., Guell, M., DiCarlo, J.E., Norville, J.E.,
and Church, G.M. (2013). RNA-guided human genome engineering via Cas9.
Science
339
, 823–826.
Mandegar, M.A., Huebsch, N., Frolov, E.B., Shin, E., Truong, A., Olvera, M.P.,
Chan, A.H., Miyaoka, Y., Holmes, K., Spencer, C.I., et al. (2016). CRISPR Inter-
ference Efficiently Induces Specific and Reversible Gene Silencing in Human
iPSCs. Cell Stem Cell
18
, 541–553.
Marraffini, L.A. (2015). CRISPR-Cas immunity in prokaryotes. Nature
526
, 55–61.
Martin, G.R. (1981). Isolation of a pluripotent cell line from early mouse
embryos cultured in medium conditioned by teratocarcinoma stem cells.
Proc. Natl. Acad. Sci. USA
78
, 7634–7638.
Maruyama, T., Dougan, S.K., Truttmann, M.C., Bilate, A.M., Ingram, J.R., and
Ploegh, H.L. (2015). Increasing the efficiency of precise genome editing with
CRISPR-Cas9 by inhibition of nonhomologous end joining. Nat. Biotechnol.
33
, 538–542.
Matano, M., Date, S., Shimokawa, M., Takano, A., Fujii, M., Ohta, Y., Wata-
nabe, T., Kanai, T., and Sato, T. (2015). Modeling colorectal cancer using
CRISPR-Cas9-mediated engineering of human intestinal organoids. Nat.
Med.
21
, 256–262.
Meister, G.E., Chandrasegaran, S., and Ostermeier, M. (2010). Heterodimeric
DNA methyltransferases as a platform for creating designer zinc finger meth-
yltransferases for targeted DNA methylation in cells. Nucleic Acids Res.
38
,
1749–1759.
Merkle, F.T., and Eggan, K. (2013). Modeling human disease with pluripotent
stem cells: from genome association to function. Cell Stem Cell
12
, 656–668.
Miller, J.D., Ganat, Y.M., Kishinevsky, S., Bowman, R.L., Liu, B., Tu, E.Y., Man-
dal, P.K., Vera, E., Shim, J.W., Kriks, S., et al. (2013). Human iPSC-based
modeling of late-onset disease via progerin-induced aging. Cell Stem Cell
13
, 691–705.
Miyaoka, Y., Chan, A.H., Judge, L.M., Yoo, J., Huang, M., Nguyen, T.D., Lizar-
raga, P.P., So, P.L., and Conklin, B.R. (2014). Isolation of single-base genome-
edited human iPS cells without antibiotic selection. Nat. Methods
11
, 291–293.
Morton, J., Davis, M.W., Jorgensen, E.M., and Carroll, D. (2006). Induction and
repair of zinc-finger nuclease-targeted double-strand breaks in Caenorhabdi-
tis elegans somatic cells. Proc. Natl. Acad. Sci. USA
103
, 16370–16375.
Nelles, D.A., Fang, M.Y., O’Connell, M.R., Xu, J.L., Markmiller, S.J., Doudna,
J.A., and Yeo, G.W. (2016). Programmable RNA Tracking in Live Cells with
CRISPR/Cas9. Cell
165
, 488–496.
Nichols, J., and Smith, A. (2009). Naive and primed pluripotent states. Cell
Stem Cell
4
, 487–492.
Niu, Y., Shen, B., Cui, Y., Chen, Y., Wang, J., Wang, L., Kang, Y., Zhao, X., Si,
W., Li, W., et al. (2014). Generation of gene-modified cynomolgus monkey via
Cas9/RNA-mediated gene targeting in one-cell embryos. Cell
156
, 836–843.
O’Connell, M.R., Oakes, B.L., Sternberg, S.H., East-Seletsky, A., Kaplan, M.,
and Doudna, J.A. (2014). Programmable RNA recognition and cleavage by
CRISPR/Cas9. Nature
516
, 263–266.
Okita, K., Ichisaka, T., and Yamanaka, S. (2007). Generation of germline-
competent induced pluripotent stem cells. Nature
448
, 313–317.
Park, I.H., Zhao, R., West, J.A., Yabuuchi, A., Huo, H., Ince, T.A., Lerou, P.H.,
Lensch, M.W., and Daley, G.Q. (2008). Reprogramming of human somatic
cells to pluripotency with defined factors. Nature
451
, 141–146.
Park, C.Y., Kim, D.H., Son, J.S., Sung, J.J., Lee, J., Bae, S., Kim, J.H., Kim,
D.W., and Kim, J.S. (2015). Functional Correction of Large Factor VIII Gene
Chromosomal Inversions in Hemophilia A Patient-Derived iPSCs Using
CRISPR-Cas9. Cell Stem Cell
17
, 213–220.
Parnas, O., Jovanovic, M., Eisenhaure, T.M., Herbst, R.H., Dixit, A., Ye, C.J.,
Przybylski, D., Platt, R.J., Tirosh, I., Sanjana, N.E., et al. (2015). A Genome-
584
Cell Stem Cell
18
, May 5, 2016
Cell Stem Cell
Review